Fractalkine expression is upregulated in the mucosa of patients with active IBD and is modulated via IL-1β, TNF-α, and IFN-γ signalling and associated with the expansion of the CX3CR1+ MNP pool [110,111,112]. This evidence concerns the gene CX3CR1 and inflammatory bowel disease.